SGLT2i: Overview of recent trials and guideline recommendations
Lecture 2 out of 3
This lecture by Nicolaus Marx was part of an accredited symposium " Teaming up to tackle cardiorenal risk in diabetes - Role of SGLT2i: How to overcome clinical inertia" held during the virtual EASD 2021.
Prof. Nikolaus Marx, Professor of Medicine / Cardiology, Head of Department of Internal Medicine I, Cardiology, Angiology, and Intensive Care Medicine, University Hospital Aachen, Germany.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant received from Boehringer Ingelheim / Lilly.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: